These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21252203)

  • 21. Review article: chronic hepatitis C--natural history and cofactors.
    Alberti A; Vario A; Ferrari A; Pistis R
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():74-8. PubMed ID: 16225479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C and diabetes: the inevitable coincidence?
    Lonardo A; Adinolfi LE; Petta S; Craxì A; Loria P
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):293-308. PubMed ID: 19344243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatitis C and diabetes mellitus].
    Kaneko Y; Takahashi M; Taneichi H; Sawada A; Suzuki K
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():633-6. PubMed ID: 12430294
    [No Abstract]   [Full Text] [Related]  

  • 24. Minimal model analysis in nondiabetic renal transplant recipients with hepatitis C.
    López R; Gentil MA; Acosta D; Escobar MJ; Sánchez F; Pereira P; Algarra GR; Astorga R
    Transplant Proc; 2005 Apr; 37(3):1446-8. PubMed ID: 15866633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gestational diabetes mellitus and subsequent development of overt diabetes mellitus.
    Damm P
    Dan Med Bull; 1998 Nov; 45(5):495-509. PubMed ID: 9850811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
    Imazeki F; Yokosuka O; Fukai K; Kanda T; Kojima H; Saisho H
    Liver Int; 2008 Mar; 28(3):355-62. PubMed ID: 18290778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II and the development of insulin resistance: implications for diabetes.
    Olivares-Reyes JA; Arellano-Plancarte A; Castillo-Hernandez JR
    Mol Cell Endocrinol; 2009 Apr; 302(2):128-39. PubMed ID: 19150387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART).
    Vigouroux C; Gharakhanian S; Salhi Y; Nguyen TH; Chevenne D; Capeau J; Rozenbaum W
    Diabetes Metab; 1999 Sep; 25(3):225-32. PubMed ID: 10499191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Change of insulin sensitivity in hepatitis C patients with normal insulin sensitivity: a 5-year prospective follow-up study variation of insulin sensitivity in HCV patients.
    Park SK; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI
    Intern Med J; 2010 Jul; 40(7):503-11. PubMed ID: 19712201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diabetes and immunology. I. Immunologic reactions linked to diabetes].
    Ekoe JM; Albert J
    Sem Hop; 1983 May; 59(21):1630-2. PubMed ID: 6310778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C.
    Negro F; Clément S
    J Viral Hepat; 2009 Oct; 16(10):681-8. PubMed ID: 19732324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of hepatitis C virus-related insulin resistance.
    Negro F
    Clin Res Hepatol Gastroenterol; 2011 May; 35(5):358-63. PubMed ID: 21354385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific phenotype associated with diabetes mellitus secondary to chronic hepatitis C infection.
    Poussier A; Lebouvier M; Penfornis A; Di Martino V; Buffier P; Verges B; Hillon P; Petit JM
    Diabet Med; 2008 Oct; 25(10):1237-40. PubMed ID: 19046205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies with insulin -I-131 in insulin resistant diabetes.
    Ibrahim MS; Abdel-Wahab MF; el-Deeb MR
    J Egypt Med Assoc; 1966; 49(11):720-7. PubMed ID: 5965036
    [No Abstract]   [Full Text] [Related]  

  • 35. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection.
    Caronia S; Taylor K; Pagliaro L; Carr C; Palazzo U; Petrik J; O'Rahilly S; Shore S; Tom BD; Alexander GJ
    Hepatology; 1999 Oct; 30(4):1059-63. PubMed ID: 10498660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of abnormal glycometabolism in patients with chronic hepatitis C and related risk factors in China.
    Wang LF; Wu CH; Shan Y; Fan XH; Huo N; Lu HY; Xu XY
    Chin Med J (Engl); 2011 Jan; 124(2):183-8. PubMed ID: 21362362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Rubenesque pregnancy: a progression towards higher blood pressure correlates with a measure of endogenous and exogenous insulin levels.
    Jovanovic-Peterson L; Meisel B; Bevier W; Peterson CM
    Am J Perinatol; 1997 Apr; 14(4):181-6. PubMed ID: 9259924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Causal relationship between hepatitis C virus core and the development of type 2 diabetes mellitus in a hepatitis C virus hyperendemic area: a pilot study.
    Kawaguchi T; Nagao Y; Tanaka K; Ide T; Harada M; Kumashiro R; Sata M
    Int J Mol Med; 2005 Jul; 16(1):109-14. PubMed ID: 15942686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diabetes mellitus secondary to liver diseases. A review (author's transl)].
    Guillon J; Charbonnel B
    Diabete Metab; 1975 Sep; 1(3):191-9. PubMed ID: 791727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.